Increased cardiac death or decreased motor vehicle accidents?

American Journal of Psychiatry

Volumn 167, Issue 2, 2010, Pages 213-

  Blume, Joshua ^a   Rostain, Anthony L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT;

ATTENTION DEFICIT DISORDER; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CLINICAL PRACTICE; DISEASE ASSOCIATION; DRIVING ABILITY; DRUG USE; HEART DEATH; INCIDENCE; JUVENILE; LETTER; PRESCRIPTION; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DEATH, SUDDEN; DEATH, SUDDEN, CARDIAC; HUMANS;

EID: 75749148414     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2009.09101388     Document Type: Letter

References (3)

1. Gould MS, Walsh BT, Munfakh JL, Kleinman M, Duan N, Olfson M, Greenhill L, Cooper T: Sudden death and use of stimulant medications in youths. Am J Psychiatry 2009; 166:992-1001
2. Barkley RA, Cox D: A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res 2007; 38:113-128
3. Verster JC, Bekker EM, de Roos M, Minova A, Eijken EJ, Kooij JJ, Buitelaar JK, Kenemans JL, Verbaten MN, Olivier B, Volkerts ER: Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial. J Psychopharmacol 2008; 22:230-237